Sanofi and Novartis have separately entered into agreements with the US government to reduce medicine prices for American patients while reinforcing long-term commitments to US-based manufacturing, research and innovation, marking a coordinated push to balance affordability with sustained pharmaceutical investment.
Pharma Manufacturing | 22/12/2025 | By News Bureau
Aptar Acquires Sommaplast, Provider of Oral Dosing Pharma Packaging Solutions
The acquisition of Sommaplast strengthens Aptar’s pharmaceutical portfolio and expands its footprint in Latin America, giving the company access to Sommaplast’s established expertise in oral dosing components and its growing customer base across Brazil’s healthcare market.
Pharma Manufacturing | 04/12/2025 | By Dineshwori
Glenmark Pharmaceuticals Receives EIR from US FDA for Monroe Facility
Glenmark Pharmaceuticals has received an Establishment Inspection Report (EIR) from the US FDA for its formulations manufacturing facility in Monroe, with a Voluntary Action Indicated (VAI) status.
Pharma Manufacturing | 27/11/2025 | By Dineshwori | 116
KLIFO Expands Manufacturing Capacity with New Authorised Clinical Supply Facility in Copenhagen
KLIFO, a leading integrated drug development and clinical supply services provider with over 30 years of expertise, has received official manufacturing and importation authorisation from the Danish Medicines Agency for its new 65,000 sq ft Abildager facility in Copenhagen.
Pharma Manufacturing | 10/10/2025 | By Darshana | 151
Dr Reddy's Welcomes Unified GST Reform to Support Pharma Manufacturing
Reddy said he expects the reform to address these critical issues, improve medicine affordability, and enhance India’s competitiveness and innovation in the global pharmaceutical supply chain. He emphasised that a reformed GST system would not only benefit patients but also reinforce India’s role in global healthcare security.
Pharma Manufacturing | 27/08/2025 | By Darshana | 178
Evonik opens German lipid manufacturing plant
The facility supports the production of all types of custom and proprietary lipids
Pharma Manufacturing | 11/03/2023 | By Sudeep Soparkar | 699
Actylis opens API manufacturing facility in Oregon, US
The 30,000 sq ft facility will manufacture innovative APIs and excipients at both clinical trial and full commercial scale
Pharma Manufacturing | 08/03/2023 | By Sudeep Soparkar | 1489
Mumbai Vaishali Pharma bags Rs 600 Cr order for antibiotics pharma products
Vaishali Pharma holds altogether 250+ brands in finished formulations
Pharma Manufacturing | 02/03/2023 | By Sudeep Soparkar | 895
Veranova completes $10 M mid-scale API expansion at Edinburgh facility
The expansion allows the company to handle highly active APIs and intermediates
<br />
Pharma Manufacturing | 13/02/2023 | By Sudeep Soparkar | 928
Bionova Scientific to expand its biologics manufacturing operations at its Fremont, California
The new facility will replace the headquarters and development centre
Pharma Manufacturing | 04/02/2023 | By Sudeep Soparkar | 903
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy